Earnings Outlook For Arcadia Biosciences
Portfolio Pulse from Benzinga Insights
Arcadia Biosciences (NASDAQ:RKDA) is scheduled to release its quarterly earnings report on March 28, 2024, with analysts expecting an EPS of $-2.58. The company's past earnings performance shows a pattern of beating EPS estimates but experiencing subsequent share price drops. Shares are currently trading at $2.332, reflecting a 71.92% decline over the last 52 weeks. Investors are likely focused on the company's guidance for future growth.
March 27, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Arcadia Biosciences is expected to report an EPS of $-2.58 for the upcoming quarter, with a history of beating estimates but facing share price declines post-announcement. Currently, shares have significantly dropped over the past year.
Given RKDA's history of beating EPS estimates but experiencing share price declines post-earnings, and considering the significant year-to-date drop in share price, it's likely that the upcoming earnings report could lead to further short-term price declines, especially if the guidance does not meet investor expectations.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100